Trials / Completed
CompletedNCT00948246
European Union (EU) Post-Market Study on Easyband®
EU Post-Market Study on Easyband®
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 112 (actual)
- Sponsor
- Allergan Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect additional safety, performance and effectiveness data of the Easyband gastric band medical device in the treatment of morbid obesity in 4 European countries where the device is a CE marked approved product.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Easyband® | The Easyband adjustable gastric band device is implanted laparoscopically around the top of the stomach to create a small pouch. Adjustments to increase or decrease the stoma size are made non-invasively by telemetric connection between an internal and external antenna. |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2011-10-01
- Completion
- 2011-12-01
- First posted
- 2009-07-29
- Last updated
- 2014-10-13
- Results posted
- 2012-11-26
Locations
4 sites across 4 countries: Belgium, Italy, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT00948246. Inclusion in this directory is not an endorsement.